These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 22503276)

  • 1. The effects of letrozole on ovarian stimulation for fertility preservation in cancer-affected women.
    Checa Vizcaíno MA; Corchado AR; Cuadri ME; Comadran MG; Brassesco M; Carreras R
    Reprod Biomed Online; 2012 Jun; 24(6):606-10. PubMed ID: 22503276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients.
    Goldrat O; Gervy C; Englert Y; Delbaere A; Demeestere I
    Hum Reprod; 2015 Sep; 30(9):2184-9. PubMed ID: 26109617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study.
    Azim AA; Costantini-Ferrando M; Oktay K
    J Clin Oncol; 2008 Jun; 26(16):2630-5. PubMed ID: 18509175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is letrozole needed for controlled ovarian stimulation in patients with estrogen receptor-positive breast cancer?
    Revelli A; Porcu E; Levi Setti PE; Delle Piane L; Merlo DF; Anserini P
    Gynecol Endocrinol; 2013 Nov; 29(11):993-6. PubMed ID: 24000936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of ovarian stimulation response in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins to patients undergoing ovarian stimulation with gonadotropins alone for elective cryopreservation of oocytes†.
    Pereira N; Hancock K; Cordeiro CN; Lekovich JP; Schattman GL; Rosenwaks Z
    Gynecol Endocrinol; 2016 Oct; 32(10):823-826. PubMed ID: 27114051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.
    Meirow D; Raanani H; Maman E; Paluch-Shimon S; Shapira M; Cohen Y; Kuchuk I; Hourvitz A; Levron J; Mozer-Mendel M; Brengauz M; Biderman H; Manela D; Catane R; Dor J; Orvieto R; Kaufman B
    Fertil Steril; 2014 Aug; 102(2):488-495.e3. PubMed ID: 24934489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation.
    Oktay K; Buyuk E; Libertella N; Akar M; Rosenwaks Z
    J Clin Oncol; 2005 Jul; 23(19):4347-53. PubMed ID: 15824416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to ovarian stimulation in patients facing gonadotoxic therapy.
    Johnson LN; Dillon KE; Sammel MD; Efymow BL; Mainigi MA; Dokras A; Gracia CR
    Reprod Biomed Online; 2013 Apr; 26(4):337-44. PubMed ID: 23415997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Random-start controlled ovarian hyperstimulation with letrozole for fertility preservation in cancer patients: case series and review of literature.
    Keskin U; Ercan CM; Yilmaz A; Babacan A; Korkmaz C; Duru NK; Ergun A
    J Pak Med Assoc; 2014 Jul; 64(7):830-2. PubMed ID: 25255597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review.
    Rodgers RJ; Reid GD; Koch J; Deans R; Ledger WL; Friedlander M; Gilchrist RB; Walters KA; Abbott JA
    Hum Reprod; 2017 May; 32(5):1033-1045. PubMed ID: 28333356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of the ovaries in women with breast cancer undergoing fertility preservation: Alternative versus standard stimulation protocols; the study protocol of the STIM-trial.
    Dahhan T; Balkenende EME; Beerendonk CCM; Fleischer K; Stoop D; Bos AME; Lambalk CB; Schats R; van Golde RJT; Schipper I; Louwé LA; Cantineau AEP; Smeenk JMJ; de Bruin JP; Reddy N; Kopeika Y; van der Veen F; van Wely M; Linn SC; Goddijn M
    Contemp Clin Trials; 2017 Oct; 61():96-100. PubMed ID: 28710053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The case for aromatase inhibitors use in oncofertility patients. Should aromatase inhibitors be combined with gonadotropin treatment in breast cancer patients undergoing ovarian stimulation for fertility preservation prior to chemotherapy? A debate.
    Fatum M; McVeigh E; Child T
    Hum Fertil (Camb); 2013 Dec; 16(4):235-40. PubMed ID: 23863119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy.
    Oktay K; Hourvitz A; Sahin G; Oktem O; Safro B; Cil A; Bang H
    J Clin Endocrinol Metab; 2006 Oct; 91(10):3885-90. PubMed ID: 16882752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative potencies of anastrozole and letrozole to suppress estradiol in breast cancer patients undergoing ovarian stimulation before in vitro fertilization.
    Azim AA; Costantini-Ferrando M; Lostritto K; Oktay K
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2197-200. PubMed ID: 17356042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High yield of oocytes without an increase in circulating estradiol levels in breast cancer patients treated with follicle-stimulating hormone and aromatase inhibitor in standard gonadotropin-releasing hormone analogue protocols.
    Ben-Haroush A; Farhi J; Ben-Aharon I; Sapir O; Pinkas H; Fisch B
    Isr Med Assoc J; 2011 Dec; 13(12):753-6. PubMed ID: 22332446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles.
    Sönmezer M; Türkçüoğlu I; Coşkun U; Oktay K
    Fertil Steril; 2011 May; 95(6):2125.e9-11. PubMed ID: 21292255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letrozole for ovulation induction and fertility preservation by embryo cryopreservation in young women with endometrial carcinoma.
    Azim A; Oktay K
    Fertil Steril; 2007 Sep; 88(3):657-64. PubMed ID: 17428480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian Stimulation in Patients With Cancer: Impact of Letrozole and BRCA Mutations on Fertility Preservation Cycle Outcomes.
    Turan V; Bedoschi G; Emirdar V; Moy F; Oktay K
    Reprod Sci; 2018 Jan; 25(1):26-32. PubMed ID: 28874104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of random-start controlled ovarian stimulation in cancer patients.
    Kim JH; Kim SK; Lee HJ; Lee JR; Jee BC; Suh CS; Kim SH
    J Korean Med Sci; 2015 Mar; 30(3):290-5. PubMed ID: 25729252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment.
    Domingo J; Guillén V; Ayllón Y; Martínez M; Muñoz E; Pellicer A; Garcia-Velasco JA
    Fertil Steril; 2012 Apr; 97(4):930-4. PubMed ID: 22283969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.